March 2013

The latest from Cogstate, leaders in optimizing the measurement of cognition

Take a gamble on market stocks

March 1, 2013

Herald Sun Criterion columnist, Tim Boreham reported on the Myer family’s 19.3 per cent investment in CogState and the use of Cognigram in Canada, which is the first test used outside of clinical trials for Alzheimers disease. Boreham states, “He (Brad O’ Connor) estimates the cognitive testing market globally is worth about $500m. Canada, in […]

Cognitive reasoning worth millions

March 1, 2013

Herald Sun’s In The Black columnist, John Beveridge reported on Cogstate’s tests and its applicability to a range of cognitive testing ranging from sports testing, cognitive training for athletes to improve performance as well as cognitive assessment for psychological conditions. Cogstate is rated as a speculative Buy. Beveridge states, “However, the really big opportunity for […]